日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of a high-throughput screening platform for C. difficile toxin synthesis inhibitors unveils meclizine as an antivirulence agent

利用高通量筛选平台筛选艰难梭菌毒素合成抑制剂,发现美克洛嗪是一种抗毒力药物。

Marreddy, Ravi K R; Nguyen, Nghi; Dureja, Chetna; McKelvey, Ann Marie; Powell, Reid; Olaitan, Abiola O; Stephan, Clifford; Hurdle, Julian G

An adaptive acceleration scheme for phase-field fatigue computations

一种用于相场疲劳计算的自适应加速方案

Heinzmann, Jonas; Carrara, Pietro; Ambati, Marreddy; Mirzaei, Amir Mohammad; De Lorenzis, Laura

Imaging the Future: Diagnosing Treatable Neurometabolic Disorders in Children

展望未来:儿童可治疗神经代谢疾病的诊断

Eda, Ishani Reddy; Ramachandran, Rajoo; Joseph, Veena M; Marreddy, Sahithi; Mounika, Arikila

Role of Advanced Magnetic Resonance Imaging in Differentiating among Glioma Subtypes and Predicting Tumor-Proliferative Behavior

先进磁共振成像技术在区分胶质瘤亚型和预测肿瘤增殖行为中的作用

Ganesan, Gunalan; Rangasami, Rajeswaran; Chandrasekharan, Anupama; Marreddy, Sahithi; Ramachandran, Rajoo

Chemical genetic analysis of enoxolone inhibition of Clostridioides difficile toxin production reveals adenine deaminase and ATP synthase as antivirulence targets

对依诺酮抑制艰难梭菌毒素产生的化学遗传学分析表明,腺嘌呤脱氨酶和ATP合酶是其抗毒力靶点。

Marreddy, Ravi K R; Phelps, Gregory A; Churion, Kelly; Picker, Jonathan; Powell, Reid; Cherian, Philip T; Bowling, John J; Stephan, Clifford C; Lee, Richard E; Hurdle, Julian G

C. difficile intoxicates neurons and pericytes to drive neurogenic inflammation

艰难梭菌通过毒害神经元和周细胞来引发神经源性炎症。

John Manion # ,Melissa A Musser # ,Gavin A Kuziel ,Min Liu ,Amy Shepherd ,Siyu Wang ,Pyung-Gang Lee ,Leo Zhao ,Jie Zhang ,Ravi K R Marreddy ,Jeffrey D Goldsmith ,Ke Yuan ,Julian G Hurdle ,Ralf Gerhard ,Rongsheng Jin ,Seth Rakoff-Nahoum ,Meenakshi Rao ,Min Dong

Ebselen Not Only Inhibits Clostridioides difficile Toxins but Displays Redox-Associated Cellular Killing

依布硒不仅能抑制艰难梭菌毒素,还能发挥与氧化还原相关的细胞杀伤作用

Ravi K R Marreddy, Abiola O Olaitan, Jordan N May, Min Dong, Julian G Hurdle

Intravenous Methylene Blue as a Rescue Therapy in the Management of Refractory Hypoxia in COVID-19 ARDS Patients: A Case Series

静脉注射亚甲蓝作为COVID-19 ARDS患者难治性低氧血症的抢救疗法:病例系列研究

Mahale, Nilesh; Godavarthy, Purushotham; Marreddy, Srinath; Gokhale, Snehal D; Funde, Pradip; Rajhans, Prasad A; Akole, Prasad V; Pawar, Balasaheb; Bhurke, Bhagyashri; Dalvi, Pradip; Marudwar, Prasanna; Gugale, Shradha; Shahane, Manasi S; Kshirsagar, Sarang N; Jog, Sameer A

The early stage peptidoglycan biosynthesis Mur enzymes are antibacterial and antisporulation drug targets for recurrent Clostridioides difficile infection

早期肽聚糖生物合成中的Mur酶是复发性艰难梭菌感染的抗菌和抗孢子形成药物靶点。

Sapkota, Madhab; Marreddy, Ravi K R; Wu, Xiaoqian; Kumar, Manish; Hurdle, Julian G

A Retrospective Observational Study of Hypoxic COVID-19 Patients Treated with Immunomodulatory Drugs in a Tertiary Care Hospital

一项回顾性观察研究:三级医院接受免疫调节药物治疗的缺氧性新冠肺炎患者

Mahale, Nilesh; Rajhans, Prasad; Godavarthy, Purushotham; Narasimhan, Vikram L; Oak, Gauri; Marreddy, Srinath; Bedekar, Amruta; Dhundi, Ujwal; Pawar, Harshwardhan S; Akole, Prasad; Pawar, Balasaheb; Bhurke, Bhagyashri; Chavan, Shailaja; Prayag, Parikshit; Purandare, Bharat; Dalvi, Pradip; Telbhare, Vishnu; Marudwar, Prasanna; Diwane, Dnyaneshwar; Shahane, Manasi; Prayag, Amrita; Gugale, Shradha; Bhor, Shreyas; Jog, Sameer